GlassScriptPhysician profile
Jillian A Perry
NPI 1508426198
$1,006.10
in general payments reported to CMS, 2019-2025
21 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.69 · 2022: $162 · 2023: $202 · 2024: $269 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $187.04 | 2022-2025 | Wegovy, Saxenda, Rybelsus |
| Abbvie INC. | $169.26 | 2023-2025 | |
| Pfizer INC. | $139.25 | 2023-2025 | |
| Exact Sciences Corporation | $56.99 | 2024-2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $54.50 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.58 | 2022-2023 | |
| Antares Pharma, INC. | $36.24 | 2024-2025 | Xyosted |
| Lilly USA, LLC | $33.60 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $33.52 | 2022-2024 | Farxiga |
| Astellas Pharma US INC | $31.52 | 2025 | Veozah |
| Indivior INC. | $29.23 | 2025 | Sublocade |
| Merz North America, INC. | $27.80 | 2024 | |
| Solta Medical, A Division of Bausch Health US, LLC | $24.86 | 2024 | Clear+Brilliant |
| Abbott Laboratories | $22.90 | 2025 | Freestyle Libre 3 |
| Halozyme INC | $19.96 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $19.73 | 2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $18.38 | 2022 | |
| Amarin Pharma, INC. | $18.30 | 2021 | |
| Biomerieux INC | $17.00 | 2025 | |
| Boston Scientific Corporation | $13.44 | 2021 | |
| Genentech USA, INC. | $11.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.